No abstract available
Keywords:
Medicare Part D; chronic rhinosinusitis; dupilumab; mepolizumab; nasal polyposis; omalizumab; out-of-pocket.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, N.I.H., Extramural
MeSH terms
-
Biological Products*
-
Chronic Disease
-
Health Expenditures
-
Humans
-
Medicare
-
Nasal Polyps* / drug therapy
-
Nasal Polyps* / epidemiology
-
Rhinitis* / drug therapy
-
Sinusitis* / drug therapy
-
United States / epidemiology